Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.

Nazem Ghasemi1, Shahnaz Razavi1, Elham Nikzad2

  • 1Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Cell Journal
|April 4, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroprotective effects of rosemary extract on white matter of prefrontal cortex in old rats.

Iranian journal of basic medical sciences·2024
Same author

The preventive effect of <i>Zingiber officinale</i> essential oil on demyelination of corpus callosum in a cuprizone rat model of multiple sclerosis.

Avicenna journal of phytomedicine·2023
Same author

Valproic acid effects on human adipose-derived stem cell differentiation into oligodendrocytes and improved remyelination in a mouse model of Multiple Sclerosis.

The International journal of developmental biology·2023
Same author

Impact of Intraventricular Human Adipose-Derived Stem Cells Transplantation with Pregnenolone Treatment on Remyelination of Corpus Callosum in A Rat Model of Multiple Sclerosis.

Cell journal·2022
Same author

Evaluation of in vivo lithium chloride effects as a GSK3-β inhibitor on human adipose derived stem cells differentiation into oligodendrocytes and re-myelination in an animal model of multiple sclerosis.

Molecular biology reports·2022
Same author

Upregulation of Neurotrophic Factors and Myelin Basic Protein in Schwann-like Cells by T3 Hormone Following Transdifferentiation of Human Adipose-derived Stem Cells.

International journal of molecular and cellular medicine·2022

Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system (CNS). Current treatments do not halt nerve tissue destruction, prompting research into new strategies like stem cell transplantation for MS.

Area of Science:

  • Neurology
  • Immunology
  • Pathogenesis of Multiple Sclerosis

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory central nervous system (CNS) disease.
  • MS pathogenesis involves genetic predisposition and environmental factors, including infections, vitamin deficiencies, and smoking.
  • Immune system activation leads to nerve demyelination and dysfunction.

Purpose of the Study:

  • To provide neurologists with current information on MS etiology, pathogenesis, diagnosis, and treatment.
  • To discuss emerging therapeutic strategies beyond conventional treatments.
  • To synthesize recent findings on the multifactorial causes of MS.

Main Methods:

  • Review of current literature and available information on Multiple Sclerosis.
Keywords:
Cell TherapyDemyelinationEtiologyMultiple Sclerosis

Related Experiment Videos

  • Analysis of etiological factors, including genetic and environmental influences.
  • Evaluation of existing and proposed therapeutic interventions for MS.
  • Main Results:

    • MS etiology is multifactorial, involving genetic susceptibility and environmental triggers.
    • Conventional therapies (anti-inflammatory, immunomodulatory) do not prevent nerve tissue destruction.
    • Stem cell transplantation is an emerging strategy for MS treatment.

    Conclusions:

    • Neurologists must stay informed about the latest MS research.
    • Understanding the multifactorial nature of MS is crucial for effective management.
    • Novel therapeutic approaches are needed to halt MS-related neurodegeneration.